Gadolinium is commonly used as a contrast agent in magnetic resonance imaging and angiography (MRIs and MRAs).  The practice may not be safe for someone who suffers kidney (renal) disease or dysfunction, because it may put the person at risk for developing a potentially life-threatening condition known as nephrogenic systemic fibrosis (NSF), also sometimes called nephrogenic fibrosing dermopathy (NFD).

If you have kidney disease or dysfunction and you have received a gadolinium-based contrast agent (OmniScan - Gadadiamid, OptiMARK - Gadoversetamide, Prohance -  Gadoteridol, Magnavist - Gadopentetate Dimeglumine, Multihance -Gadobenate Dimeglumine)  for an MRI or MRA, you may want talk to your doctor as soon as possible.  You should see your doctor immediately if you have any of the following early symptoms of NSF:
    •   Burning, itching, swelling of the skin 
    •    Development of "thick skin" or "hard skin" which appears shiny 
    •    Red or dark patches of skin 
    •    Yellow spots on the whites of the eyes 
    •    Stiff joints 
    •    Deep pain in the hip bones or ribs 
    •    Generalized muscle weakness. 

NSF can move to other places in the body, and in rare cases can lead to death.   The first thing to do if you feel you may have NSF is seek diagnosis and get treated.  New treatments for NSF may slow or arrest its development, and some treatments may improve the symptoms.  However, there is no known cure for NSF.

Speak with an attorney if you have been diagnosed with NSF, or if you fear your doctor is not doing the tests needed to diagnose or rule it out.  Only an attorney knowledgeable about gadolinium and gadolinium lawsuits can tell you if you may be able to recover compensation.

Back to Pharmaceutical Drugs.